Skip to main content

Cycurion Reports Full Year 2024 Financial Results

MCLEAN, Va., April 17, 2025 (GLOBE NEWSWIRE) -- Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, reports financial results for full year ended December 31, 2024, and provides a corporate update highlighting a year of strategic execution, operational discipline, and solid financial performance.

Cycurion is poised for a strong 2025, driven by a strategic overhaul focused on sustainable growth and innovation. Over the past year, the company streamlined operations, significantly cutting General and Administrative (G&A) expenses while boosting gross profit for greater financial strength. Cycurion invested heavily in AI-driven technology, sharpening its competitive edge. By pivoting away from low-margin clients to high-value opportunities, the Company has built a robust framework for organic growth while paving the way for expansion, entering 2025 with clear momentum and vision.

Financial Highlights

  • Revenues of $17.8 million
  • SG&A expenses reduced by 47.5%, demonstrating operational efficiency and tighter strategic focus
  • Adjusted EBITDA of $2.3 million, up 58.9% year-over-year with an expanded margin of 12.9% vs $1.4 million (7.4% margin) in FY2023, reflecting strong cost management and scalable operations 
  • Net income of $1.2 million, a significant turnaround from a net loss of $2.1 million in FY2023 — marking Cycurion’s first full year of net profitability 
  • Earnings per share improvement to $0.07 basic and $0.01 fully diluted, versus $(0.14) in both categories in FY2023 
  • Free Cash Flow improvement to $(1.8) million from $(2.5) million despite growth investments in personnel and platform development 

2024 & YTD 2025 Strategic, Technological and Corporate Milestones

Cycurion significantly expanded its next-generation product and services portfolio, further solidifying its position as a trusted partner in advanced cybersecurity solutions: 

  • Listed & Began Trading on Nasdaq: Completed merger with Western Acquisition Ventures in February 2025
  • U.S. Launch of AI-driven SaaS ARx Cybersecurity Platform: New high margin, AI-driven cybersecurity solution expands Company’s reach following strong initial reception in the government and public sectors in March 2025
  • Launched Cyber Shield Managed Security Services Platform (MSSP) Launch: Includes SOC as Service, External Attack Surface Management, Web Application Firewall and Virtual CISO Support & Consulting
  • Expanded Partnership with Journal Technologies: Secured $22 million multi-year contract with State Police Agency
  • Strengthened Board of Directors Appointing Two Highly Accomplished IT Professionals: Kevin O’Brien and Reginald Bailey bring a combined 55 years of IT, Big Data and AI industry, entrepreneurial and C-suite experience to Cycurion

Management Commentary
Kevin Kelly, Cycurion CEO, stated, “We are pleased with Cycurion’s 2024 performance, especially with our ability to produce meaningful adjusted EBITDA growth coupled with positive net income of $1.2 million. This is particularly significant given an 8.2% revenue decrease due to non-recurring, one-time equipment purchases in 2023. Our strong foundation positions us for continued growth with tremendous momentum with both current and new clients, which will become evident over the next 3-6 months underpinning our belief of a promising 2025.”

About Cycurion
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies, Cloudburst Security, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients with a commitment to securing the digital future.

Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.

Many factors could cause Cycurion’s actual results, performance, or achievements to be materially different from any future results, performance, or achievements described in this press release, including words such as “continue”, “expect”, “intend”, “will”, “hope”, “should”, “would”, “may”, “potential”, and other similar expressions. Such factors could include, among others, those detailed in its Registration Statement on Form S-4, as filed with the Securities and Exchange Commission (the “SEC”). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled “Risk Factors” in that filing with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and Cycurion does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. Cycurion cannot assure that such statements will prove to be accurate as actual results, and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Investor Contact:
CORE IR
investors@cycurion.com

Media Contact:
Phone: (703) 555-0123
Email: media@cycurion.com

Non-GAAP Financial Measures
Statements in this release include financial information presented in accordance with accounting principles generally accepted in the United States ("GAAP") and also include non-GAAP financial measures that are provided as additional information to enhance the overall understanding of the Company's current financial performance and not as an alternative to the consolidated interim financial statements presented in accordance with GAAP. Management uses these non-GAAP measures (earnings before interest, taxes, depreciation, and amortization ("EBITDA"), Adjusted EBITDA, Adjusted EBITDA margin, Free Cash Flow) to evaluate the Company's financial performance. These terms might not be calculated in the same manner as, and thus might not be comparable to, similarly titled measures reported by other companies. The financial information tables that accompany this press release include reconciliations of net income to non-GAAP financial measures.

EBITDA, Adjusted EBITDA, and Adjusted EBITDA margin provide a measure of the Company's operating results in a manner that is focused on the performance of the Company's core business on an ongoing basis, by removing the effects of non-operating and certain non-cash expenses. These non-operating and non-cash items are specifically identified in the reconciliations of GAAP measures to Non-GAAP measures that accompany this release.

Free Cash Flow provides useful information to investors about the amount of cash generated by the business that can be used for strategic opportunities and is computed as Cash Flows from Operating Activities less both the Purchase of Property and Equipment & Purchase of Intangible Assets.


CYCURION, INC. AND ITS SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
 
  December 31,  December 31, 
  2024  2023 
Assets      
Current assets        
Cash $38,742  $607,869 
Restricted cash  2,048   - 
Accounts receivable, net  10,353,708   7,093,371 
Other receivables  434,391   455,979 
Due from sponsor  106,421   - 
Note receivable - WAVS  -   200,000 
Prepaid expenses and other current assets  99,463   56,015 
Total current assets $11,034,773  $8,413,234 
         
Non-current assets        
Deposit for acquisition target  2,000,000   2,000,000 
Fixed assets, net  4,175,169   3,779,310 
Intangible assets, net  25,000   - 
Security deposits  10,351   10,351 
Goodwill  6,592,304   6,592,304 
Investments held in Trust Account  1,834,540   - 
Total non-current assets  14,637,364   12,381,965 
Total Assets $25,672,137  $20,795,199 
         
Liabilities, Mezzanine and Stockholders’ Equity        
Current liabilities        
Bank loan-revolving credit line  3,249,067   2,996,753 
Bank loan-current portion  774,095   742,141 
Loans payable  408,516   408,516 
Subordinated convertible promissory notes  3,333,335   3,333,335 
Promissory notes  2,624,111   1,561,111 
Loans payable - related parties  (325,600)  587,400 
Accounts payable  3,552,674   2,066,760 
Due to Trust Account  106,421   - 
Accrued liabilities  3,601,242   2,158,255 
Income Tax Payable  12,500   - 
Franchise tax payable  13,200   - 
Excise tax payable  1,157,161   - 
Advance from Sponsor  330,000   - 
Deferred revenue  189,150   253,902 
Total current liabilities  19,025,872   14,108,173 
         
Long-term loan payable  146,798   146,798 
Series A convertible preferred stock ($0.001 par value, 500,000 shares designated, 345,528 issued and outstanding)  1,294,117   1,294,117 
Total non-current liabilities  1,440,915   1,440,915 
         
Total Liabilities $20,466,787  $15,549,088 
         
Commitments and contingencies        
         
Mezzanine Equity        
Common stock subject to possible redemption, $0.0001 par value, 173,879 shares at redemption value of approximately $11.03 per share at December 31, 2024  1,917,309   - 
         
Stockholders’ Equity        
Preferred stock ($0.0001 par value, 20,000,000 shares authorized)        
Series B convertible preferred stock ($1.00 stated value, 3,000 shares designated, 3,000 and 2,000 issued and outstanding, respectively)  -   - 
Series C convertible preferred stock ($82.46 stated value, 5,000 shares designated, 4,851 issued and outstanding)  -   - 
Common stock ($0.0001 par value, 70,000,000 shares authorized, 10,592,607 and 7,341,607 shares issued and outstanding)  1,059   1,028 
Additional paid in capital  6,670,060   9,678,045 
Accumulated deficit  (3,383,078)  (4,432,962)
Total Stockholders’ Equity  3,288,041   5,246,111 
Total Liabilities and Stockholders’ Equity $25,672,137  $20,795,199 



CYCURION, INC. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
 
  Years ended 
  December 31, 
  2024  2023 
       
Net revenues $17,582,335  $19,350,208 
Cost of revenues  14,136,742   16,707,148 
Gross profit  3,445,593   2,643,060 
         
Operating expenses:        
Selling, general and administrative expenses  1,215,763   2,316,649 
         
Operating income (loss)  2,229,830   326,411 
         
Other income (expenses):        
Interest income  20,211   - 
Interest expense  (1,202,936)  (2,074,089)
Other income  28,020   - 
Other expense  (25,241)  (345,548)
Other income (expenses)  (1,179,946)  (2,419,637)
         
Profit (loss) before income taxes  1,049,884   (2,093,226)
         
Provision before income taxes  -   3,787 
         
Net income (loss) $1,049,884  $(2,097,013)
         
Comprehensive income (loss) $1,049,884  $(2,097,013)
         
Net income (loss) per common share        
Basic income (loss) per common share $0.07  $(0.14)
Diluted loss per common share $0.01  $(0.14)
         
Basic and diluted weighted average common shares outstanding  14,968,215   14,782,442 
Diluted weighted average common shares outstanding  89,495,790   14,782,442 



CYCURION, INC. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
  Years ended 
  December 31, 
  2024  2023 
Cash flows from operating activities        
Net income (loss) $1,049,884  $(2,097,013)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Stock based compensation  10,000   327,499 
Amortization of debt discount  -   1,094,131 
Depreciation of fixed assets  27,142   25,822 
Changes in operating assets and liabilities:        
Change of right of use asset and lease liabilities  -   (7,810)
Accounts and other receivables  (3,238,749)  (4,636,805)
Advance and prepayments to suppliers  (43,448)  (40,917)
Accounts and other payables  908,854   3,105,223 
Accrued interest  (20,211)  - 
Deferred revenue  (64,752)  242,099 
Net cash used in operating activities  (1,371,280)  (1,987,771)
         
Cash flows from investing activities        
Acquisition of WAVS  2,048   - 
Promissory note issued by WAVS  (439,114)  (200,000)
Purchase of plant and equipment  (423,001)  (506,707)
Purchase of Intangible asset  (25,000)  - 
Net cash used in investing activities  (885,067)  (706,707)
         
Cash flows from financing activities        
Proceeds from private placement  1,000,000   2,000,000 
Net proceeds from line of credit  252,314   5,346 
Proceeds from all bank borrowings  -   - 
Repayment of all bank borrowings  31,954   (193,305)
Proceeds from loans payable  -   339,500 
Repayments of loans payable  -   (29,379)
Proceeds from notes payable by WAVS  255,000   - 
Proceeds from notes payable  205,000   550,000 
Proceeds from notes payable - related parties  15,000   534,000 
Repayments of notes payable - related parties  -   - 
Net cash provided by financing activities  1,759,268   3,206,162 
         
Net change in cash and restricted cash  (497,079)  511,684 
Cash –beginning of period  607,869   96,185 
Cash–end of period $110,790  $607,869 
         
Restricted cash - end of period $2,048  $- 
Cash - end of period $38,742  $- 
         
Supplementary cash flow information:        
Interest paid $-  $501,337 
Income taxes paid $-  $- 



CYCURION, INC. AND ITS SUBSIDIARIES
RECONCILIATION OF GAAP TO NON-GAAP MEASURES (Unaudited)
 
  Years ended 
  December 31, 
   2024   2023 
         
Net income (loss) $1,049,884  $(2,097,013)
Provision for income taxes  -   3,787 
Interest expense  1,202,936   2,074,089 
Interest income  (20,211)  - 
Amortization of debt discount  -   1,094,131 
Depreciation of fixed assets  27,142   25,822 
         
EBITDA (non-GAAP measure) $2,259,751  $1,100,816 
         
Stock compensation expense  10,000   327,499 
         
Adjusted EBITDA (non-GAAP measure) $2,269,751  $1,428,315 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.